Table of Content
1. Executive Summary | Oncolytic Virus Cancer Therapy Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Virus Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Virus Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Virus Type, 2023 to 2033
5.3.1. Genetically Engineered Oncolytic Viruses
5.3.1.1. Herpes Simplex Virus
5.3.1.2. Adenovirus
5.3.1.3. Vaccinia Virus
5.3.2. Oncolytic Wild-type Viruses
5.3.2.1. Reovirus
5.3.2.2. Newcastle Disease Virus
5.3.2.3. Vesicular Stomatitis Virus
5.4. Y-o-Y Growth Trend Analysis By Virus Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Virus Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Solid Tumors
6.3.1.1. Breast Cancer
6.3.1.2. Prostate Cancer
6.3.1.3. Lung Cancer
6.3.1.4. Glioblastoma
6.3.2. Melanoma
6.3.2.1. Hematological Malignancies
6.3.2.2. Lymphoma
6.3.2.3. Leukemia
6.3.2.4. Myeloma
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Cancer Research Institutes
7.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa(MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Virus Type
9.2.3. By Application
9.2.4. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Virus Type
9.3.3. By Application
9.3.4. By End-use
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Virus Type
10.2.3. By Application
10.2.4. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Virus Type
10.3.3. By Application
10.3.4. By End-use
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Virus Type
11.2.3. By Application
11.2.4. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Virus Type
11.3.3. By Application
11.3.4. By End-use
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Virus Type
12.2.3. By Application
12.2.4. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Virus Type
12.3.3. By Application
12.3.4. By End-use
12.4. Key Takeaways
13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of Middle East and Africa(MEA)
13.2.2. By Virus Type
13.2.3. By Application
13.2.4. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Virus Type
13.3.3. By Application
13.3.4. By End-use
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Virus Type
14.1.2.2. By Application
14.1.2.3. By End-use
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Virus Type
14.2.2.2. By Application
14.2.2.3. By End-use
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Virus Type
14.3.2.2. By Application
14.3.2.3. By End-use
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Virus Type
14.4.2.2. By Application
14.4.2.3. By End-use
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Virus Type
14.5.2.2. By Application
14.5.2.3. By End-use
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Virus Type
14.6.2.2. By Application
14.6.2.3. By End-use
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Virus Type
14.7.2.2. By Application
14.7.2.3. By End-use
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Virus Type
14.8.2.2. By Application
14.8.2.3. By End-use
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Virus Type
14.9.2.2. By Application
14.9.2.3. By End-use
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Virus Type
14.10.2.2. By Application
14.10.2.3. By End-use
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Virus Type
14.11.2.2. By Application
14.11.2.3. By End-use
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Virus Type
14.12.2.2. By Application
14.12.2.3. By End-use
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Virus Type
14.13.2.2. By Application
14.13.2.3. By End-use
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Virus Type
14.14.2.2. By Application
14.14.2.3. By End-use
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Virus Type
14.15.2.2. By Application
14.15.2.3. By End-use
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Virus Type
14.16.2.2. By Application
14.16.2.3. By End-use
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Virus Type
14.17.2.2. By Application
14.17.2.3. By End-use
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Virus Type
14.18.2.2. By Application
14.18.2.3. By End-use
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Virus Type
14.19.2.2. By Application
14.19.2.3. By End-use
14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By Virus Type
14.20.2.2. By Application
14.20.2.3. By End-use
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Virus Type
15.3.3. By Application
15.3.4. By End-use
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Oncolytics Biotech Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Amgen Inc.
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Sorrento Therapeutics
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Transgene SA
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Daiichi Sankyo Company
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Shanghai Sunway Biotech Co, Ltd
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Takara Bio Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. PsiOxus Therapeutics
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. SillaJen Inc
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. ViroCure
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Virus Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Virus Type, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Virus Type, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Europe Market Value (US$ Million) Forecast by Virus Type, 2018 to 2033
Table 15: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Asia Pacific Market Value (US$ Million) Forecast by Virus Type, 2018 to 2033
Table 19: Asia Pacific Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 20: Asia Pacific Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 21: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: MEA Market Value (US$ Million) Forecast by Virus Type, 2018 to 2033
Table 23: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 24: MEA Market Value (US$ Million) Forecast by End-use, 2018 to 2033
List of Charts
Figure 1: Global Market Value (US$ Million) by Virus Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by End-use, 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Virus Type, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Virus Type, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Virus Type, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 17: Global Market Attractiveness by Virus Type, 2023 to 2033
Figure 18: Global Market Attractiveness by Application, 2023 to 2033
Figure 19: Global Market Attractiveness by End-use, 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Virus Type, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Application, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by End-use, 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Virus Type, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Virus Type, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Virus Type, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 37: North America Market Attractiveness by Virus Type, 2023 to 2033
Figure 38: North America Market Attractiveness by Application, 2023 to 2033
Figure 39: North America Market Attractiveness by End-use, 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Virus Type, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Application, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by End-use, 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Virus Type, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Virus Type, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Virus Type, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 57: Latin America Market Attractiveness by Virus Type, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033
Figure 59: Latin America Market Attractiveness by End-use, 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Europe Market Value (US$ Million) by Virus Type, 2023 to 2033
Figure 62: Europe Market Value (US$ Million) by Application, 2023 to 2033
Figure 63: Europe Market Value (US$ Million) by End-use, 2023 to 2033
Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Market Value (US$ Million) Analysis by Virus Type, 2018 to 2033
Figure 69: Europe Market Value Share (%) and BPS Analysis by Virus Type, 2023 to 2033
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Virus Type, 2023 to 2033
Figure 71: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 74: Europe Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 75: Europe Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 77: Europe Market Attractiveness by Virus Type, 2023 to 2033
Figure 78: Europe Market Attractiveness by Application, 2023 to 2033
Figure 79: Europe Market Attractiveness by End-use, 2023 to 2033
Figure 80: Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Asia Pacific Market Value (US$ Million) by Virus Type, 2023 to 2033
Figure 82: Asia Pacific Market Value (US$ Million) by Application, 2023 to 2033
Figure 83: Asia Pacific Market Value (US$ Million) by End-use, 2023 to 2033
Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Virus Type, 2018 to 2033
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Virus Type, 2023 to 2033
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Virus Type, 2023 to 2033
Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 97: Asia Pacific Market Attractiveness by Virus Type, 2023 to 2033
Figure 98: Asia Pacific Market Attractiveness by Application, 2023 to 2033
Figure 99: Asia Pacific Market Attractiveness by End-use, 2023 to 2033
Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 101: MEA Market Value (US$ Million) by Virus Type, 2023 to 2033
Figure 102: MEA Market Value (US$ Million) by Application, 2023 to 2033
Figure 103: MEA Market Value (US$ Million) by End-use, 2023 to 2033
Figure 104: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: MEA Market Value (US$ Million) Analysis by Virus Type, 2018 to 2033
Figure 109: MEA Market Value Share (%) and BPS Analysis by Virus Type, 2023 to 2033
Figure 110: MEA Market Y-o-Y Growth (%) Projections by Virus Type, 2023 to 2033
Figure 111: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 112: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 113: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 114: MEA Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 115: MEA Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 116: MEA Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 117: MEA Market Attractiveness by Virus Type, 2023 to 2033
Figure 118: MEA Market Attractiveness by Application, 2023 to 2033
Figure 119: MEA Market Attractiveness by End-use, 2023 to 2033
Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
